2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
About this PQI
The purpose of this PQI is to discuss clinical considerations of epcoritamab (Epkinly®) treatment for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Belantamab Mafodotin (Blenrep) for the Management of Multiple Myeloma
Last Updated: 04/03/2026
PQI: HER2 Immunohistochemistry Testing in Metastatic Breast Cancer: Guiding Treatment Decisions and the Role of Sacituzumab Govitecan
Last Updated: 02/12/2026
PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia
Last Updated: 10/07/2025
PQI: Streamlining Enrollment in the Medicare Prescription Payment Plan (MPPP)
Last Updated: 09/17/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Capivasertib (Truqap) Patient Management
Last Updated: 04/15/2026
PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)
Last Updated: 04/01/2026
PQI in Action: Darolutamide (Nubeqa)
Last Updated: 01/22/2026
PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers
Last Updated: 12/17/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 01/06/2026
Treatment Support Kit: Bi-Specific
Last Updated: 12/12/2025
Treatment Support Kit: Mirdametinib
Last Updated: 06/10/2025
Treatment Support Kit: Abemaciclib
Last Updated: 04/11/2025
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Epcoritamab and GemOx
Last Updated: 04/06/2026
Glofitamab and GemOx
Last Updated: 04/06/2026
Rituximab, Cyclophosphamide, Vincristine and Prednisone
Last Updated: 03/30/2026
Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone
Last Updated: 02/16/2026
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
Rituximab, Cyclophosphamide, Vincristine and Prednisone
Last Updated: 03/30/2026
Lenalidomide and Rituximab
Last Updated: 03/10/2026
Epcoritamab and R2
Last Updated: 02/10/2026
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Last Updated: 10/22/2025
Patient Education Sheet
Patient Education Sheet
PQI in Action
Patient Education Sheet
Epcoritamab and GemOx
Last Updated: 04/06/2026
Epcoritamab and R2
Last Updated: 02/10/2026
PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Last Updated: 10/09/2025
Epcoritamab
Last Updated: 08/16/2025
PQI in Action
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
PQI in Action: Capivasertib (Truqap) Patient Management
Last Updated: 04/15/2026
Loncastuximab Tesirine
Last Updated: 04/10/2026
Epcoritamab and GemOx
Last Updated: 04/06/2026
Glofitamab and GemOx
Last Updated: 04/06/2026